[5] Motion and control technologies manufacturer Parker Hannifin is funding further development, and plans to release the first commercial version of the exoskeleton in 2015.
[5] It also uses functional electrical stimulation to enervate the muscles of paralyzed patients, improving their strength and circulation,[11] and can be quickly disassembled for removal.
[12] In October 2012, Parker Hannifin signed an exclusive licensing agreement with Vanderbilt University for the right to develop and manufacture a commercial version of the exoskeleton, which it plans to release under the name Indego.
[6][1] Whereas current commercial exoskeletons can cost as much as $140,000, Parker Hannifin hopes to exploit its manufacturing capabilities and the Vanderbilt model's lightweight design to ensure that the Indego is significantly cheaper.
[7] In December 2014, Parker Hannifin invested in Freedom Innovations, a California-based prosthetic technology company with which it had a pre-existing partnership, to further the development of Indego.